@rattaurus3
Active 12 months ago
Taken together, the findings of the present study demonstrate that RP11‑340F14.6 specifically binds to P2X7R, which results in the continuous activation of P2X7R. Thus, RP11‑340F14.6 may serve as a promising therapeutic target for the treatment of JIA.Supplemental oxygen therapy can be life‑saving for premature infants. Our previous study revea […] View